(Q39631420)

English

Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays

scientific article published on June 2012

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Differential sensitivity of von Willebrand factor (VWF) 'activity' assays to large and small VWF molecular weight forms: a cross-laboratory study comparing ristocetin cofactor, collagen-binding and mAb-based assays (English)

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

author name string

E J Favaloro

1

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

R Bonar

2

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

K Chapman

3

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

M Meiring

4

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

D Funk Adcock

5

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

publication date

1 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

1043-1054

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Von Willebrand disease: local diagnosis and management of a globally distributed bleeding disorder.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Update on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Diagnosis and classification of von Willebrand disease: a review of the differential utility of various functional von Willebrand factor assays

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

A short history of diagnostic tests for von Willebrand disease: in memory of Barry Firkin (1930 to 2001) and Ted Zimmerman (1937 to 1988).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Desmopressin therapy to assist the functional identification and characterisation of von Willebrand disease: differential utility from combining two (VWF:CB and VWF:RCo) von Willebrand factor activity assays?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Time to think outside the box? Proposals for a new approach to future pharmacokinetic studies of von Willebrand factor concentrates in people with von Willebrand disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Methodologies and clinical utility of ADAMTS-13 activity testing

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Comparison of a new automated von Willebrand factor activity assay with an aggregation von Willebrand ristocetin cofactor activity assay for the diagnosis of von Willebrand disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Diagnosis and management of adult patients with von Willebrand disease in South Australia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Von Willebrand factor assay proficiency testing. The North American Specialized Coagulation Laboratory Association experience

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

N-acetylcysteine reduces the size and activity of von Willebrand factor in human plasma and mice

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Use of a novel platelet function analyzer (PFA-100) with high sensitivity to disturbances in von Willebrand factor to screen for von Willebrand's disease and other disorders

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

What a polyclonal antibody sees in von Willebrand factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Improved performance characteristics of the von Willebrand factor ristocetin cofactor activity assay using a novel automated assay protocol

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Validation of improved performance characteristics for the automated von Willebrand factor ristocetin cofactor activity assay

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Reducing errors in identification of von Willebrand disease: the experience of the royal college of pathologists of australasia quality assurance program

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Generation and breakdown of soluble ultralarge von Willebrand factor multimers

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Evaluation of von Willebrand factor activity in factor VIII/von Willebrand factor concentrates with the automated von Willebrand factor: activity IL test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

von Willebrand Disease Laboratory Diagnosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Laboratory diagnosis of von Willebrand disease: results from a prospective and blind study in 32 laboratories worldwide using lyophilized plasmas

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2012.04729.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2012.04729.X

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

13 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39631420&oldid=2093741215"